| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 09/22/2004 | EP1460133A1 Nucleic acids with the aid of which plants having an altered metabolite content can be produced |
| 09/22/2004 | EP1460132A1 Antibodies with specific immunoreactivity to thyroid carcinoma cells |
| 09/22/2004 | EP1460131A2 Production of recombinant blood clotting factors in human cell lines |
| 09/22/2004 | EP1460130A1 Potentiometric dna microarray, process for producing the same and method of analyzing nucleic acid |
| 09/22/2004 | EP1460129A2 An alpha-amylase from pyrococcus |
| 09/22/2004 | EP1460088A1 Humanized anti-CD4 antibody with immunosuppressive properties |
| 09/22/2004 | EP1460085A1 Genes and proteins for the biosynthesis of the glycopeptide antibiotic teicoplanin |
| 09/22/2004 | EP1460083A1 High density immobilization of nucleic acids |
| 09/22/2004 | EP1459756A1 REMOVAL PROMOTERS AND INHIBITOR FOR APOPTOSIS CELLS i IN VIVO /i |
| 09/22/2004 | EP1459727A1 Nonhuman model animal unresponsive to immunopotentiating synthetic compound |
| 09/22/2004 | EP1459076A1 Modular systems and methods for using sample processing devices |
| 09/22/2004 | EP1459070A2 Methods for diagnosis and treatment of epithelial-derived cancers, such as colorectal cancers and kidney cancers |
| 09/22/2004 | EP1459063A2 Screening method for compounds that modulate neuronal activity |
| 09/22/2004 | EP1458894A2 Method for the detection and/or identification of the original animal species in animal matter contained in a sample |
| 09/22/2004 | EP1458888A2 Methods of treating psychosis and schizophrenia based on polymorphisms in the cntf gene |
| 09/22/2004 | EP1458887A2 HIGH RESOLUTION TYPING SYSTEM FOR PATHOGENIC $i(E. COLI) |
| 09/22/2004 | EP1458883A2 Screening method for agents useful in treating diabetes |
| 09/22/2004 | EP1458880A1 Isolation tool for viable c-kit expressing cells |
| 09/22/2004 | EP1458879A2 Method for producing a transgenic organism using a lentiviral expression vector such as eiav |
| 09/22/2004 | EP1458878A1 Method of increasing the transgene-coded biomolecule content in organisms |
| 09/22/2004 | EP1458877A2 Cotton alpha-globulin promoter for seed-specific expression of transgenes |
| 09/22/2004 | EP1458876A2 Improved methods and means for delivering inhibitory rna to plants and applications thereof |
| 09/22/2004 | EP1458875A2 Methods for the transformation of vegetal plastids |
| 09/22/2004 | EP1458874A2 Method for modifying plant morphology, biochemistry and physiology comprising expression of plant cytokinin oxidase |
| 09/22/2004 | EP1458873A2 D-galacturonate reductase of fragaria ananassa and its use in methods for increasing production of vitamin c in plants |
| 09/22/2004 | EP1458872A1 An efficient system for rna silencing |
| 09/22/2004 | EP1458871A2 Soluble recombinant protein production |
| 09/22/2004 | EP1458870A1 COMPOSITIONS AND PROCESSES USING siRNA, AMPHIPATHIC COMPOUNDS AND POLYCATIONS |
| 09/22/2004 | EP1458869A1 Alleles of the glucokinase gene coryneform bacteria |
| 09/22/2004 | EP1458868A2 Genes and proteins involved in the biosynthesis of lipopeptides |
| 09/22/2004 | EP1458867A2 Gene promoters |
| 09/22/2004 | EP1458866A2 Modified tridegins, production and use thereof as transglutaminase inhibitors |
| 09/22/2004 | EP1458865A2 Human vanilloid receptor protein and polynucleotide sequence encoding same |
| 09/22/2004 | EP1458864A1 Tgf-beta-specific covalently closed antisense molecule |
| 09/22/2004 | EP1458863A1 A system for stable expression of sirnas in mammalian cells |
| 09/22/2004 | EP1458862A2 Suppression of polymeric alleles |
| 09/22/2004 | EP1458861A2 Ides, an igg-degrading enzyme of streptococcus pyogenes |
| 09/22/2004 | EP1458860A2 Production of butyrylcholinesterases in transgenic mammals |
| 09/22/2004 | EP1458858A2 Histone h3 methyltransferase polypeptide |
| 09/22/2004 | EP1458857A1 Hxhv virus, nucleic material, peptide material and uses |
| 09/22/2004 | EP1458855A2 Method for the generation of proliferating and differentiating cell lines |
| 09/22/2004 | EP1458854A2 Cellular compositions and methods of making and using them |
| 09/22/2004 | EP1458852A1 Compositions for the in vitro derivation and culture of embryonic stem (es) cell lines with germline transmission capability and for the culture of adult stem cells |
| 09/22/2004 | EP1458849A2 Differentiation of human embryonic stem cells in avian embryos |
| 09/22/2004 | EP1458848A2 Nucleic acid nematicides |
| 09/22/2004 | EP1458759A2 Human antibodies against human glycoprotein vi and their use |
| 09/22/2004 | EP1458758A2 Adiponectin fragments and conjugates |
| 09/22/2004 | EP1458757A1 Process for the purification and/or isolation of biologically active granulocyte colony stimulating factor |
| 09/22/2004 | EP1458756A1 Chemokine mutants acting as chemokine antagonists |
| 09/22/2004 | EP1458755A2 Novel g-protein coupled receptors and dna sequences thereof |
| 09/22/2004 | EP1458754A2 Novel death associated proteins of the thap family and related par4 pathways involved in apoptosis control |
| 09/22/2004 | EP1458753A1 Modified bacterial surface layer proteins |
| 09/22/2004 | EP1458752A2 Polypeptides of pseudomonas aeruginosa |
| 09/22/2004 | EP1458750A2 Mutated hiv tat |
| 09/22/2004 | EP1458741A2 Rna interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid |
| 09/22/2004 | EP1458740A2 Nucleic acid labeling by thermoanaerobacter thermohydrosulfuricus dna polymerase i variants |
| 09/22/2004 | EP1458739A2 Antisense modulation of human fxr expression |
| 09/22/2004 | EP1458738A2 Thermus oshimai nucleic acid polymerases |
| 09/22/2004 | EP1458737A2 Biosynthetic gene cluster for the maytansinoid antitumor agent ansamitocin |
| 09/22/2004 | EP1458736A2 Recombinant bovine thrombin |
| 09/22/2004 | EP1458486A1 Array plates and method for constructing array plates |
| 09/22/2004 | EP1458485A2 Methods and devices for removal of organic molecules from biological mixtures using a hydrophilic solid support in a hydrophobic matrix |
| 09/22/2004 | EP1458411A2 Anti-rank ligand monoclonal antibodies useful in treatment of rank ligand mediated disorders |
| 09/22/2004 | EP1458410A2 Stabilised mrna tumour vaccine |
| 09/22/2004 | EP1458403A2 Compositions and methods for the treatment and clinical remission of psoriasis |
| 09/22/2004 | EP1458241A2 Modified antigen-presenting cells |
| 09/22/2004 | EP1458240A2 Nucleic acid constructs useful for glucose regulated production of human insulin in somatic cell lines |
| 09/22/2004 | EP1458234A1 Disruption of the prostaglandin e synthase 2 gene |
| 09/22/2004 | EP1458230A1 Production of recombinant antibodies by means of fusion with elastin-like peptides |
| 09/22/2004 | EP1409713A4 ASSAY FOR MEASURING FACTOR VIIa-ANTITHROMBIN COMPLEXES |
| 09/22/2004 | EP1381266A4 Tomato plants that exhibit resistance to $i(botrytis cinerea) |
| 09/22/2004 | EP1350104A4 Presenilin enhancers |
| 09/22/2004 | EP1320624B1 Silicatein-mediated synthesis of amorphous silicates and siloxanes and use thereof |
| 09/22/2004 | EP1313677B1 Method for obtaining a surface activation of a solid support for building biochips microarrays |
| 09/22/2004 | EP1294944A4 Detection of nucleic acids by type-specific hybrid capture method |
| 09/22/2004 | EP1280819A4 Methods for the purification and aqueous fiber spinning of spider silks and other structural proteins |
| 09/22/2004 | EP1243658B1 Method of measuring deacetylase activity and method of screening inhibitor or promoter of these enzymes |
| 09/22/2004 | EP1234054A4 Methods for detecting polypeptides regulating signal transduction pathways |
| 09/22/2004 | EP1230390B1 Method for the production of biopolymers with modified properties |
| 09/22/2004 | EP1229593B1 Photodetector |
| 09/22/2004 | EP1218396B1 Antibodies specific for fullerenes |
| 09/22/2004 | EP1187629B1 Adjuvant composition comprising saponin and an immunostimulatory oligonucleotide |
| 09/22/2004 | EP1173766B1 A tenascin-c isoform as a marker for neoplasias |
| 09/22/2004 | EP1147122A4 Methods for altering organ mass, controlling fertility and enhancing asexual reproduction in plants |
| 09/22/2004 | EP1099755B1 Novel gene and transformant carrying the same |
| 09/22/2004 | EP1077255B1 Nicotianamine synthase and gene encoding the same |
| 09/22/2004 | EP1040203A4 Nucleic acid ligand diagnostic biochip |
| 09/22/2004 | EP1019520A4 SCREENING METHODS TO DETECT mRNA TARGETS OF EDITING ENZYMES |
| 09/22/2004 | EP1007691B1 Methods and compositions for synthesis of long chain polyunsaturated fatty acids |
| 09/22/2004 | EP1005539B1 Ikk-alpha proteins, nucleic acids and methods |
| 09/22/2004 | EP1003871B1 Trichoderma reesei swollenin protein and encoding dna sequence |
| 09/22/2004 | EP1001750B1 Stable particulate complexes with neutral or negative globale charge of lamellar structure |
| 09/22/2004 | EP0990044B1 A method for in vitro molecular evolution of protein function |
| 09/22/2004 | EP0978569B1 Method of dna sequencing |
| 09/22/2004 | EP0975774B1 Bacterial plasmids |
| 09/22/2004 | EP0970225B1 Improved metallo-endopeptidases |
| 09/22/2004 | EP0917566B1 Recombinant blood-coagulation proteases |
| 09/22/2004 | EP0915970B1 Type c lectins |
| 09/22/2004 | EP0914442B1 Avian polynucleotide vaccine formula |
| 09/22/2004 | EP0904371B1 Use of the green fluorescent protein as a screenable marker for plant transformation |